Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis

NCT00293072 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus
ANCA Associated Vasculitis

Interventions

DRUG: Rituximab

Sponsor

Cambridge University Hospitals NHS Foundation Trust

Collaborators

[object Object]